Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Preclinical Development: Overview01:28

Preclinical Development: Overview

4.8K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

4.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.7K
Biopharmaceutical Factors Influencing Drug Product Design: Overview01:22

Biopharmaceutical Factors Influencing Drug Product Design: Overview

544
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
544
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.3K
Clinically Relevant Drug Product Specifications: Methods of Establishment01:29

Clinically Relevant Drug Product Specifications: Methods of Establishment

300
Product specifications define the acceptable quality of a pharmaceutical product by ensuring identity, purity, potency, and strength. These specifications serve as benchmarks during development, manufacturing, and post-approval quality control. Clinically relevant specifications are particularly important because they directly relate to a drug's safety and efficacy in clinical use.Dissolution studies are critical biopharmaceutic tools that link in vitro behavior to in vivo performance. They...
300
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

1.9K
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
1.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Isolation of Redox Active Disilyl-Dithiolene Compound: Chemical Bonding by EDA-NOCV Analyses.

Chemistry, an Asian journal·2026
Same author

Interaction of η<sup>2</sup>-C<sub>2</sub>B<sub>10</sub>H<sub>10</sub> and Its Derivatives with Group-X Transition Metals: A Theoretical Study Using DFT.

Inorganic chemistry·2025
Same author

Overcoming barriers to medical countermeasures: Strengthening global biosecurity.

Human vaccines & immunotherapeutics·2025
Same author

An Overview of Recent Patents and Future Perspective Based on Cyclodextrin Complexation.

Recent advances in drug delivery and formulation·2023
Same author

Retraction Note: Increased Aβ<sub>42</sub>-α7-like nicotinic acetylcholine receptor complex level in lymphocytes is associated with apolipoprotein E4-driven Alzheimer's disease pathogenesis.

Alzheimer's research & therapy·2022
Same author

Liposomes: Advancements and innovation in the manufacturing process.

Advanced drug delivery reviews·2020

Related Experiment Video

Updated: Apr 28, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K

Preclinical formulations: insight, strategies, and practical considerations.

Sanket M Shah1, Ankitkumar S Jain, Ritu Kaushik

  • 1Department of Pharmaceutics, Bombay College of Pharmacy, Kalina, Santacruz (E), Mumbai, 400098, India.

AAPS Pharmscitech
|June 13, 2014
PubMed
Summary

Pharmaceutical scientists face challenges with new chemical entities (NCEs) due to poor water solubility. This review guides selecting preclinical formulation strategies to enhance NCE bioavailability and absorption.

More Related Videos

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
08:47

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation

Published on: September 28, 2022

1.8K
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
08:20

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Published on: March 31, 2021

5.7K

Related Experiment Videos

Last Updated: Apr 28, 2026

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules
09:55

Radiosynthesis, Quality Control, and Small Animal Positron Emission Tomography Imaging of 68Ga-Labelled Nano Molecules

Published on: October 4, 2024

1.0K
Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation
08:47

Experimental Quantification of Interactions Between Drug Delivery Systems and Cells In Vitro: A Guide for Preclinical Nanomedicine Evaluation

Published on: September 28, 2022

1.8K
Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries
08:20

Systematic Approach to Identify Novel Antimicrobial and Antibiofilm Molecules from Plants' Extracts and Fractions to Prevent Dental Caries

Published on: March 31, 2021

5.7K

Area of Science:

  • Pharmaceutical Science
  • Drug Discovery and Development

Background:

  • New chemical entities (NCEs) require extensive characterization during preclinical testing.
  • Poor water solubility is a common challenge for NCEs, leading to bioavailability issues and potential drug candidate failure.
  • Effective formulation strategies are crucial for overcoming solubility limitations and ensuring successful preclinical evaluation.

Purpose of the Study:

  • To review preclinical formulation strategies for enhancing the bioavailability of new chemical entities (NCEs).
  • To provide guidance on selecting appropriate formulation approaches based on NCE physicochemical properties.
  • To offer comprehensive information on available excipients for preclinical formulation development.

Main Methods:

  • Review of existing literature on preclinical formulation strategies.
  • Analysis of physicochemical properties influencing NCE bioavailability.
  • Compilation of information on a wide range of pharmaceutical excipients.

Main Results:

  • Identification of various preclinical formulation approaches to improve NCE solubility and bioavailability.
  • Detailed insights into the role of excipients in designing effective preclinical formulations.
  • Illustrative examples highlighting key aspects of preclinical formulation development.

Conclusions:

  • Strategic selection of preclinical formulation approaches is vital for overcoming solubility-related bioavailability issues in NCEs.
  • Understanding NCE physicochemical properties and available excipients aids in designing successful formulations.
  • This review serves as a valuable resource for academic and industrial scientists in preclinical formulation development.